Clinical Trials Directory

Trials / Terminated

TerminatedNCT02891863

Low Energy Therapy to Convert Ventricular Tachycardias

Low Energy Therapy Application to Convert Ventricular Tachycardias (LEVER)

Status
Terminated
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The LEVER study is a prospective, unblinded, non-randomized, first in human feasibility study that will assess and characterize early safety and effectiveness of low energy therapies in converting monomorphic ventricular tachycardias (MVTs).

Detailed description

The LEVER study is a prospective, unblinded, non-randomized, first in human feasibility study that will assess and characterize early safety and effectiveness of low energy therapies in converting monomorphic ventricular tachycardias (MVTs). Subjects must be already indicated for standard of care VT procedure during which VT is likely to be induced (such as VT testing, VT ablation, VT mapping, or VT risk stratification testing.) The study patches will be applied to the subject's torso, and the patches will be connected to the LEVER Acute Study System. Pacing capture threshold capture may be assessed. If monomorphic VT is induced and reaches at least 170bpm (350ms/cycle), one or more of the low energy therapies will be applied under oversight of the investigator, in an attempt to treat and convert the VT.

Conditions

Interventions

TypeNameDescription
DEVICELEVER Acute Study SystemThe LEVER Acute Study System is an acute pacing and shock delivery system intended for investigational use only. The LEVER Acute Study System is intended for acute conversion testing of monomorphic ventricular tachycardia by one of three different VT conversion methods.

Timeline

Start date
2015-09-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2016-09-08
Last updated
2017-07-17
Results posted
2017-07-17

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT02891863. Inclusion in this directory is not an endorsement.